Ongoing selection for a uniquely human null allele of SIGLEC12 in world-wide populations may protect against the risk of advanced carcinomas

FASEB Bioadv. 2021 Mar 30;3(4):278-279. doi: 10.1096/fba.2021-00036. eCollection 2021 Apr.

Authors

Shoib S Siddiqui^{1

2}, Michael Vaill¹, Ajit Varki¹

Affiliations

¹ Departments of Medicine and Cellular and Molecular Medicine Glycobiology Research and Training Center, and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA.
² Present address: School of Life and Medical Sciences University of Hertfordshire Hatfield UK.

No abstract available

Grant support

R01 GM032373/GM/NIGMS NIH HHS/United States